First Patient in the RESTORE Clinical Study of Revi™ System for Urge Urinary Incontinence Treated in Tampa, Florida

February 28, 2024 UCBN News, Syndication Comments Off on First Patient in the RESTORE Clinical Study of Revi™ System for Urge Urinary Incontinence Treated in Tampa, Florida

Participants now being recruited for RESTORE study to expand the evidence base for Revi, a minimally invasive, FDA-authorized, patient-centric tibial neuromodulation therapy PARK CITY, Utah, Feb. 28, 2024 /PRNewswire/ — BlueWind Medical, Ltd. today announced that Dr. Osvaldo Padron of…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Related Articles

No Picture
News

Intera Oncology Showcases Intera 3000 Hepatic Artery Infusion (HAI) Pump at the Annual Cholangiocarcinoma Foundation Conference

April 12, 2023 UCBN News Comments Off on Intera Oncology Showcases Intera 3000 Hepatic Artery Infusion (HAI) Pump at the Annual Cholangiocarcinoma Foundation Conference

BOSTON–(BUSINESS WIRE)– #HAIpump–Intera Oncology® Inc., manufacturer of the only FDA-approved pump for Hepatic Artery Infusion (HAI) therapy for the treatment of intrahepatic cholangiocarcinoma (bile duct cancer confined to the liver) and colorectal cancer liver metastases, […]